Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.2%

3 terminated out of 71 trials

Success Rate

90.6%

+4.1% vs benchmark

Late-Stage Pipeline

10%

7 trials in Phase 3/4

Results Transparency

7%

2 of 29 completed with results

Key Signals

2 with results91% success

Data Visualizations

Phase Distribution

45Total
Not Applicable (31)
Early P 1 (3)
P 1 (4)
P 3 (1)
P 4 (6)

Trial Status

Completed29
Unknown14
Recruiting13
Not Yet Recruiting6
Active Not Recruiting5
Terminated3

Trial Success Rate

90.6%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (71)

Showing 20 of 20 trials
NCT07568366Early Phase 1Not Yet RecruitingPrimary

AI in Endoscopic Transsphenoidal Surgery

NCT03465618Phase 1Active Not Recruiting

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

NCT00001452Completed

Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex

NCT07247526Not ApplicableCompletedPrimary

Effect of Foot Bath on Anxiety and Physiological Parameters

NCT04569591Not ApplicableRecruiting

DDAVP for Pituitary Adenoma

NCT06826170Not ApplicableCompleted

Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)

NCT07493447Early Phase 1Not Yet Recruiting

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

NCT04074642Not ApplicableCompletedPrimary

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

NCT07460232Early Phase 1Not Yet Recruiting

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

NCT07456878Phase 1RecruitingPrimary

Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

NCT07446036Active Not Recruiting

Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery

NCT07335315RecruitingPrimary

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

NCT06584123Not ApplicableRecruitingPrimary

Molecular Pituitary Imaging Using 18F-FET PET

NCT07316101Not ApplicableNot Yet RecruitingPrimary

Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

NCT04081701Phase 4Recruiting

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

NCT06831461Not ApplicableRecruiting

Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

NCT07034859Phase 4Enrolling By InvitationPrimary

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

NCT03583528Active Not Recruiting

DOTATOC PET/CT for Imaging NET Patients

NCT05822817Phase 4CompletedPrimary

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

NCT06973824RecruitingPrimary

A Twenty-years' Experience in Pituitary Disease.

Scroll to load more

Research Network

Activity Timeline